Reshape memory T cell landscape in CML patients' blood by tyrosine kinase inhibitors
{{output}}
Background: CML, a blood cancer characterized by excessive myeloid cell proliferation, stems from the BCR-ABL1 gene fusion. This research aimed to uncover why leukemic stem cells resist treatment and explore innovative immune-bas... ...
